By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic gene developer DNA 2.0 said today that it will use a grant from the National Science Foundation to continue to advance its synthetic biology technologies, with a specific focus on mammalian cells.

The firm plans to use the Small Business Innovation Research award to extend its gene optimization algorithms for protein expression, which is used in producing hosts for human therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.